Topical treatment of cutaneous candidiasis with 5-fluorocytosine compared with nystatin. 1974

H Gisslén, and K Hersle, and H Mobacken

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009761 Nystatin Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002179 Candidiasis, Cutaneous Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed) Moniliasis, Cutaneous
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D005260 Female Females
D005437 Flucytosine A fluorinated cytosine analog that is used as an antifungal agent. 5-Fluorocytosine,Alcobon,Ancobon,Ancotil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

H Gisslén, and K Hersle, and H Mobacken
January 1975, Ginecologia y obstetricia de Mexico,
H Gisslén, and K Hersle, and H Mobacken
August 1974, The Journal of infectious diseases,
H Gisslén, and K Hersle, and H Mobacken
January 1972, Medicina,
H Gisslén, and K Hersle, and H Mobacken
July 1974, British medical journal,
H Gisslén, and K Hersle, and H Mobacken
August 1974, British medical journal,
H Gisslén, and K Hersle, and H Mobacken
November 1982, Annals of allergy,
H Gisslén, and K Hersle, and H Mobacken
January 1979, Current medical research and opinion,
H Gisslén, and K Hersle, and H Mobacken
October 1958, North Carolina medical journal,
H Gisslén, and K Hersle, and H Mobacken
February 1974, Archives of disease in childhood,
H Gisslén, and K Hersle, and H Mobacken
April 1973, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!